Histone Methylation Regulation as a Potential Target for Non-alcoholic Fatty Liver Disease

Area of Science:

• Biochemistry
• Molecular Biology
• Metabolic Diseases

Background:

• Epigenetic modifications, particularly histone methylation, are increasingly recognized for their role in the pathogenesis of metabolic diseases like non-alcoholic fatty liver disease (NAFLD).
• While the involvement of histone methylation in NAFLD is acknowledged, a comprehensive understanding of its regulatory mechanisms remains incomplete.
• This review addresses the critical need for a detailed overview of histone methylation regulation in the context of NAFLD.

Approach:

• A systematic literature search was conducted in the PubMed database using keywords such as 'histone', 'histone methylation', 'NAFLD', and 'metabolism'.
• References from key identified articles were also reviewed to ensure comprehensive coverage of the topic.
• The review synthesizes current knowledge on how histone methylation influences gene expression in NAFLD.

Key Points:

• Histone methylation enzymes interact with transcription factors under conditions like nutritional stress, targeting key glycolipid metabolism genes.
• These modifications regulate the transcriptional activity of genes involved in NAFLD pathogenesis.
• Histone methylation plays a crucial role in mediating inter-organ metabolic crosstalk relevant to NAFLD development and progression.

Conclusions:

• Histone methylation and demethylation are significant regulators of key glycolipid metabolism genes in NAFLD.
• Emerging evidence suggests potential therapeutic strategies involving dietary interventions or agents targeting histone methylation to improve NAFLD.
• Further research is essential to fully elucidate the therapeutic potential of targeting histone methylation in NAFLD and enhance clinical translation.